hackettg

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Clarithromycin 125mg/5ml and 250mg/5ml oral suspensions are now available to meet normal demand. As a result the Serious Shortage Protocols (SSPs), SSP053 for Clarithromycin 125mg/5ml oral suspension and SSP054 for Clarithromycin 250mg/5ml oral suspension expire at 23.59pm on Friday 19 July 2024. [...]

The post Expiry of two Clarithromycin SSPs (SSP053 and SSP054) appeared first on Community Pharmacy England.

Drug alert number: EL (24)A/26 Date issued: 04 July 2024 Kent Pharma UK is recalling various batches of Itraconazole 10mg/ml Oral Solution as a precautionary measure due to out of specification in the appearance of the solution, particularly the presence of suspended particles or clusters of crystals: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK) PL [...]

The post MHRA Class 2 Medicines Recall: Itraconazole 10mg/ml Oral Solution (Kent Pharma UK) appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 July 2024. PART XVIIIB – Drugs, medicines and others substances that may be ordered only in certain circumstances Contractors should note the addition of GnRH analogue to [...]

The post Drug Tariff Watch – July 2024 appeared first on Community Pharmacy England.

Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) Drug alert number: EL (24)A/24 Date issued: 24 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Grepid 75 mg film coated tablets (Kent Pharma Livery) Company name: PHARMATHEN S.A. Product name: [...]

The post MHRA Class 4 Medicines Defect Information: Grepid 75 mg film coated tablets (Kent Pharma Livery) appeared first on Community Pharmacy England.

Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) Drug alert number: EL (24)A/19 Date issued: 5 June 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) Company name: Neuraxpharm UK Ltd Product name: Atomoxetine [...]

The post MHRA Class 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg Capsules (Neuraxpharm UK Ltd) appeared first on Community Pharmacy England.